These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6300582)

  • 21. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.
    Cohen ML; Fuller RW; Kurz KD
    Hypertension; 1983; 5(5):676-81. PubMed ID: 6311738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat.
    Terrón JA
    Br J Pharmacol; 1997 Jun; 121(3):563-71. PubMed ID: 9179401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
    Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H
    Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat.
    Pettersson A; Gradin K; Hedner T; Persson B
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):394-7. PubMed ID: 2993926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.
    Winter JC; Rabin RA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):682-9. PubMed ID: 1359109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
    Gandolfi O; Barbaccia ML; Costa E
    Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
    Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular smooth muscle serotonin and alpha-adrenoceptors.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1983; 10(3):265-7. PubMed ID: 6313264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T; Arnt J; Hyttel J
    Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of the hypotensive effect of ketanserin.
    Fozard JR
    J Cardiovasc Pharmacol; 1982; 4(5):829-38. PubMed ID: 6182416
    [No Abstract]   [Full Text] [Related]  

  • 35. Urapidil analogues are potent ligands of the 5-HT1A receptor.
    Gross G; Schüttler K; Xin X; Hanft G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha 2-adrenoceptor antagonist SK&F 104078 has high affinity for 5-HT1A and 5-HT2 receptors.
    Kilpatrick AT; Brown CM; MacKinnon AC; Spedding M
    Eur J Pharmacol; 1989 Jul; 166(2):315-8. PubMed ID: 2571511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rats.
    Xu J; Chuang DM
    Biochem Pharmacol; 1987 Jul; 36(14):2353-8. PubMed ID: 3038121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are drugs that act both on serotonin receptors and alpha 1-adrenoceptors more potent hypotensive agents than those that act only on alpha 1-adrenoceptors?
    Ramage AG
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S30-4. PubMed ID: 2459511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor mechanisms for 5-hydroxytryptamine in isolated human umbilical artery and vein.
    Tuncer M; Doğan N; Oktay S; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):17-27. PubMed ID: 2864904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
    Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.